TSE:OGI Organigram (OGI) Stock Price, News & Analysis C$1.18 -0.01 (-0.84%) As of 11/13/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and Trends About Organigram Stock (TSE:OGI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Organigram alerts:Sign Up Key Stats Today's RangeC$1.14▼C$1.2050-Day RangeC$1.18▼C$1.5952-Week RangeC$1.14▼C$3.09Volume514,502 shsAverage Volume199,575 shsMarket CapitalizationC$170.10 millionP/E Ratio1.96Dividend YieldN/APrice TargetC$3.13Consensus RatingBuy Company Overview Organigram Global Inc. is listed on the NASDAQ Global Select Market and TSX. The Company's wholly owned subsidiary, Organigram Inc., is a licensed cultivator and processor. Through its acquisition of Sanity Group GmbH ('Sanity Group'), Organigram participates in the German medical cannabis market and other emerging markets within Europe. Organigram is focused on producing high-quality cannabis for adult consumers, as well as extending the Company's global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O' Buds, SHRED, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK. Through its acquisition of Sanity Group, Organigram's European brands include Vayamed, avaay, ZOIKS, Endosane Pharmaceuticals, VAAY, and Grashaus Projects. Organigram operates facilities in Moncton, New Brunswick and Lac Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. Read More Organigram Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreOGI MarketRank™: 3.447868852455 of 5 starsOrganigram scored higher than 69% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingOrganigram has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.Upside PotentialOrganigram has a consensus price target of C$3.13, representing about 164.8% upside from its current price of C$1.18.Amount of Analyst CoverageOrganigram has received no research coverage in the past 90 days.Read more about Organigram's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram is 1.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.40.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram is 1.96, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.56.Price to Earnings Growth RatioOrganigram has a PEG Ratio of 0.42. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioOrganigram has a P/B Ratio of 0.33. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for OGI. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOrganigram does not currently pay a dividend.Dividend GrowthOrganigram does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A Search Interest4 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.MarketBeat Follows1 people have added Organigram to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Organigram insiders have not sold or bought any company stock.Percentage Held by Insiders31.32% of the stock of Organigram is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions3.31% of the stock of Organigram is held by institutions.Read more about Organigram's insider trading history. Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OGI Stock News HeadlinesOrganigram Global Inc. has entered into an arrangement agreement to acquire Aurora Cannabis Inc..November 4, 2026 | marketscreener.comMOrganigram (TSE:OGI) Stock Falls 5.9% - Should You Sell?November 4, 2026 | americanbankingnews.comThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.November 15 at 1:00 AM | Porter & Company (Ad)Organigram to Acquire Aurora Cannabis for $5.58 a ShareNovember 3, 2026 | finance.yahoo.comOrganigram Remains Undervalued After Record-Breaking QuarterSeptember 10, 2026 | seekingalpha.comOrganigram Global Inc. (OGI:CA) Q3 2026 Earnings Call TranscriptAugust 11, 2026 | seekingalpha.comOrganigram surges 10% on record Q3 resultsAugust 11, 2026 | seekingalpha.comOrganigram global Q3 earnings previewAugust 10, 2026 | msn.comSee More Headlines OGI Stock Analysis - Frequently Asked Questions How have OGI shares performed this year? Organigram's stock was trading at C$2.31 at the beginning of 2026. Since then, OGI shares have decreased by 48.9% and is now trading at C$1.18. How were Organigram's earnings last quarter? Organigram Holdings Inc. (TSE:OGI) posted its quarterly earnings data on Tuesday, August, 11th. The company reported C$0.77 EPS for the quarter. The firm had revenue of C$105.78 million for the quarter. Organigram had a net margin of 28.02% and a trailing twelve-month return on equity of 21.99%. How do I buy shares of Organigram? Shares of OGI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some other companies that Organigram investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACB), Green Organic Dutchman (TGOD) and Kushco (KSHB). Company Calendar Last Earnings8/11/2026Today11/15/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolTSE:OGI CIKN/A Webwww.organigram.ca Phone844-644-4726FaxN/AEmployees1,139Year FoundedN/APrice Target and Rating Average Price Target for OrganigramC$3.13 High Price TargetC$3.25 Low Price TargetC$3.00 Potential Upside/Downside+164.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)C$0.60 Trailing P/E Ratio1.96 Forward P/E RatioN/A P/E Growth0.42Net Income-C$57.23 million Net Margins28.02% Pretax MarginN/A Return on Equity21.99% Return on Assets-5.56% Debt Debt-to-Equity Ratio6.48 Current Ratio2.61 Quick Ratio2.62 Sales & Book Value Annual SalesC$309.18 million Price / Sales0.55 Cash FlowC$0.31 per share Price / Cash Flow3.85 Book ValueC$3.59 per share Price / Book0.33Miscellaneous Outstanding Shares144,153,000Free FloatN/AMarket CapC$170.10 million OptionableNot Optionable Beta1.44 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (TSE:OGI) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.